Study of Feraheme demonstrates Improvements in Fatigue and Quality Of Life in Iron Deficiency Anemia PatientsWALTHAM, Mass. December 3, 2018 – AMAG Pharmaceuticals, Inc. (NASDAQ:AMAG) today announced that research supported by the Company, “Sustained Improvements More
WALTHAM, Mass., November 29, 2018 – As part of the company’s annual grant program to support research to reduce preterm birth and preeclampsia and More
"I get to wear a lot of different hats in an industry that provides very fast-paced and interesting work along with the opportunity to solve the puzzle of treatments for difficult diseases."
Senior Manager, Regulatory Affairs & Medical Writing